Cargando…

Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions

[Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle....

Descripción completa

Detalles Bibliográficos
Autores principales: Krüger, Dennis M., Glas, Adrian, Bier, David, Pospiech, Nicole, Wallraven, Kerstin, Dietrich, Laura, Ottmann, Christian, Koch, Oliver, Hennig, Sven, Grossmann, Tom N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682607/
https://www.ncbi.nlm.nih.gov/pubmed/29028171
http://dx.doi.org/10.1021/acs.jmedchem.7b01221
_version_ 1783278128256253952
author Krüger, Dennis M.
Glas, Adrian
Bier, David
Pospiech, Nicole
Wallraven, Kerstin
Dietrich, Laura
Ottmann, Christian
Koch, Oliver
Hennig, Sven
Grossmann, Tom N.
author_facet Krüger, Dennis M.
Glas, Adrian
Bier, David
Pospiech, Nicole
Wallraven, Kerstin
Dietrich, Laura
Ottmann, Christian
Koch, Oliver
Hennig, Sven
Grossmann, Tom N.
author_sort Krüger, Dennis M.
collection PubMed
description [Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts.
format Online
Article
Text
id pubmed-5682607
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-56826072017-11-15 Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions Krüger, Dennis M. Glas, Adrian Bier, David Pospiech, Nicole Wallraven, Kerstin Dietrich, Laura Ottmann, Christian Koch, Oliver Hennig, Sven Grossmann, Tom N. J Med Chem [Image: see text] Macrocyclic peptides can interfere with challenging biomolecular targets including protein–protein interactions. Whereas there are various approaches that facilitate the identification of peptide-derived ligands, their evolution into higher affinity binders remains a major hurdle. We report a virtual screen based on molecular docking that allows the affinity maturation of macrocyclic peptides taking non-natural amino acids into consideration. These macrocycles bear large and flexible substituents that usually complicate the use of docking approaches. A virtual library containing more than 1400 structures was screened against the target focusing on docking poses with the core structure resembling a known bioactive conformation. Based on this screen, a macrocyclic peptide 22 involving two non-natural amino acids was evolved showing increased target affinity and biological activity. Predicted binding modes were verified by X-ray crystallography. The presented workflow allows the screening of large macrocyclic peptides with diverse modifications thereby expanding the accessible chemical space and reducing synthetic efforts. American Chemical Society 2017-10-13 2017-11-09 /pmc/articles/PMC5682607/ /pubmed/29028171 http://dx.doi.org/10.1021/acs.jmedchem.7b01221 Text en Copyright © 2017 American Chemical Society This is an open access article published under a Creative Commons Non-Commercial No Derivative Works (CC-BY-NC-ND) Attribution License (http://pubs.acs.org/page/policy/authorchoice_ccbyncnd_termsofuse.html) , which permits copying and redistribution of the article, and creation of adaptations, all for non-commercial purposes.
spellingShingle Krüger, Dennis M.
Glas, Adrian
Bier, David
Pospiech, Nicole
Wallraven, Kerstin
Dietrich, Laura
Ottmann, Christian
Koch, Oliver
Hennig, Sven
Grossmann, Tom N.
Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title_full Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title_fullStr Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title_full_unstemmed Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title_short Structure-Based Design of Non-natural Macrocyclic Peptides That Inhibit Protein–Protein Interactions
title_sort structure-based design of non-natural macrocyclic peptides that inhibit protein–protein interactions
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5682607/
https://www.ncbi.nlm.nih.gov/pubmed/29028171
http://dx.doi.org/10.1021/acs.jmedchem.7b01221
work_keys_str_mv AT krugerdennism structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT glasadrian structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT bierdavid structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT pospiechnicole structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT wallravenkerstin structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT dietrichlaura structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT ottmannchristian structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT kocholiver structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT hennigsven structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions
AT grossmanntomn structurebaseddesignofnonnaturalmacrocyclicpeptidesthatinhibitproteinproteininteractions